We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
-6.13%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$24.3B
AUM Growth
-$2.75B
Cap. Flow
-$241M
Cap. Flow %
-0.99%
Top 10 Hldgs %
6.96%
Holding
1,806
New
215
Increased
810
Reduced
545
Closed
187

Sector Composition

Rank Sector Weight
1 Financials 16.78%
2 Technology 13.51%
3 Consumer Discretionary 13.35%
4 Industrials 13.14%
5 Healthcare 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMP
1551
DELISTED
Cempra, Inc.
CEMP
$18K ﹤0.01%
658
+50
+8% +$1.86K
NBIX icon
1552
Neurocrine Biosciences
NBIX
$16.4B
$17K ﹤0.01%
438
+34
+8% +$1.64K
CPHD
1553
DELISTED
Cepheid Inc
CPHD
$16K ﹤0.01%
362
+31
+9% +$1.65K
ARWR icon
1554
Arrowhead Research
ARWR
$12.2B
$15K ﹤0.01%
+2,542
New +$16K
XNCR icon
1555
Xencor
XNCR
$1.47B
$15K ﹤0.01%
1,234
+93
+8% +$1.82K
FLXN
1556
DELISTED
Flexion Therapeutics, Inc.
FLXN
$15K ﹤0.01%
1,034
+77
+8% +$1.81K
AMPH icon
1557
Amphastar Pharmaceuticals
AMPH
$892M
$14K ﹤0.01%
1,182
+105
+10% +$1.57K
LCNB icon
1558
LCNB Corp
LCNB
$281M
$14K ﹤0.01%
865
UE icon
1559
Urban Edge Properties
UE
$2.78B
$14K ﹤0.01%
637
ACAD icon
1560
Acadia Pharmaceuticals
ACAD
$4.93B
$13K ﹤0.01%
379
+31
+9% +$1.29K
AGEN
1561
Agenus
AGEN
$324M
$13K ﹤0.01%
139
+11
+9% +$1.63K
TGTX icon
1562
TG Therapeutics
TGTX
$7.64B
$13K ﹤0.01%
1,278
+97
+8% +$1.45K
FLTX
1563
DELISTED
Fleetmatics Group PLC
FLTX
$13K ﹤0.01%
+265
New +$12.6K
CLDX icon
1564
Celldex Therapeutics
CLDX
$3.22B
$12K ﹤0.01%
78
+7
+10% +$1.98K
CRIS icon
1565
Curis
CRIS
$8.85M
$12K ﹤0.01%
3
CLVS
1566
DELISTED
Clovis Oncology, Inc.
CLVS
$12K ﹤0.01%
134
+13
+11% +$1.13K
QRVO icon
1567
Qorvo
QRVO
$8.4B
$11K ﹤0.01%
235
ADMS
1568
DELISTED
Adamas Pharmaceuticals
ADMS
$11K ﹤0.01%
660
+57
+9% +$1.3K
FOMX
1569
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$11K ﹤0.01%
1,473
+131
+10% +$1.33K
XLE icon
1570
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
$9K ﹤0.01%
+296
New +$9.98K
EXAS
1571
DELISTED
Exact Sciences
EXAS
$8K ﹤0.01%
465
+41
+10% +$942
PCRX icon
1572
Pacira BioSciences
PCRX
$979M
$8K ﹤0.01%
193
+18
+10% +$1.1K
WPM icon
1573
Wheaton Precious Metals
WPM
$55.8B
$8K ﹤0.01%
698
KERX
1574
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$7K ﹤0.01%
2,083
-1,006
-33% -$6.74K
RLYP
1575
DELISTED
RELYPSA INC COM
RLYP
$6K ﹤0.01%
347
+29
+9% +$797

Similar funds

Victory Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Victory Capital Management held 1,806 positions worth $24.3B, down 10% from $27B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Victory Capital Management's Q3 2015 filing shows 215 new, 810 increased, 545 reduced and 187 closed positions. Its largest new stake was COLUMBIA PIPELINE GROUP IN COM STK (DE): 3,388,718 shares worth $62M. The largest sale was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $125M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Victory Capital Management's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 3,388,718 shares worth $62M.
  • Victory Capital Management added most to Dollar General in Q3 2015, an estimated $114M increase.
  • Victory Capital Management's biggest Q3 2015 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $125M.
  • Victory Capital Management fully exited Willis Towers Watson in Q3 2015, selling an estimated $120M.
  • Victory Capital Management's ten largest holdings make up 7% of its $24.3B portfolio in Q3 2015.
  • Victory Capital Management opened 215 new positions and closed 187 in Q3 2015.
  • Victory Capital Management's portfolio value fell 10% quarter-over-quarter to $24.3B.

Based on Victory Capital Management's 13F filing for Q3 2015, filed 6 Nov 2015.